An update on clinical trials and new treatments in IgA nephropathy​ (2023)

  Рет қаралды 3,134

Leicester IgA Nephropathy

Leicester IgA Nephropathy

8 ай бұрын

Dr Chee Kay Cheung provided an update on the latest clinical trials and further information on new treatments for IgAN, at the 2023 UK IgA Nephropathy Patient Information Day.
Donate to the Leicester IgA Nephropathy Research Group giving.le.ac.uk/single-gift.h...

Пікірлер: 4
@tanerpikdoken6552
@tanerpikdoken6552 8 ай бұрын
Thank you for this - I watched it with great interest as we have a relative with pretty progressed igaN. I wanted to ask for your opinion about the treatment with Tarpeyo/Kinpeygo which is, to my understanding, a relatively newly approved drug from pharma company Calliditas Therapeutics. If I understand correctly, it is the only one which seem to halt the disease progression by lowering eGFR and proteinuria. I would greatly appreciate any insight into this. Thank you!
@kevinwellwrought2024
@kevinwellwrought2024 6 ай бұрын
IGA has no treatment and such videos might just be advertising for selling drugs
@MYBEES1
@MYBEES1 4 ай бұрын
There are many drugs that can help in slowing the progression of the disease. Part of the problem is getting diagnosed early as most people with IGAN don’t know they have it until the later stages of the disease. I have it myself.
@kevinwellwrought2024
@kevinwellwrought2024 4 ай бұрын
@@MYBEES1 yes, for example, cortisol can help slow down proteinuria but the side effects outweight the benefits. However, if proteinuria is caught while it is still under 1000 mdgl it is easier to control it. To this date there is no treatment for IGA nephropathy.
Columbia Medicine CME - Novel Treatment Strategies in lgA Nephropathy
35:05
Columbia Department of Medicine
Рет қаралды 651
IgA Nephropathy Basics (including an update on new treatments).
1:07:20
Leicester IgA Nephropathy
Рет қаралды 4,9 М.
когда повзрослела // EVA mash
00:40
EVA mash
Рет қаралды 4,5 МЛН
IgA Nephropathy Clinical Trial: VISIONARY Trial (Sibeprenlimab)
32:12
National Kidney Foundation
Рет қаралды 90 М.
SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
1:14:50
GlomCon Foundation
Рет қаралды 1,2 М.
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
7:43
Harvard Medical School Continuing Education
Рет қаралды 15 М.
Clinical Trial Series: IgA Nephropathy
1:27:15
GlomCon Foundation
Рет қаралды 9 М.
Behind the Mystery: IgA Nephropathy
9:09
The Balancing Act
Рет қаралды 19 М.
Summary of Clinical Trials Testing Novel Treatments for IgAN
23:05
Leicester IgA Nephropathy
Рет қаралды 764
What are SGLT2 inhibitors and how do they affect kidney disease?
10:55
Plant Based Kidney Health
Рет қаралды 10 М.
ABCs of Kidney Disease | Management of Chronic Kidney Disease
6:30
Johns Hopkins Medicine
Рет қаралды 50 М.
когда повзрослела // EVA mash
00:40
EVA mash
Рет қаралды 4,5 МЛН